Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides. - Wikidata - awgldk - TriplyDB

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.

http://www.wikidata.org/entity/Q34244772

about

An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice The metalloproteases meprin α and meprin β: unique enzymes in inflammation, neurodegeneration, cancer and fibrosis.Cerebrospinal fluid amyloid-β 2-42 is decreased in Alzheimer's, but not in frontotemporal dementia Truncated and modified amyloid-beta species.Clinical applications of MS-based protein quantification.Neutral polymers as coatings for high resolution electrophoretic separation of Aβ peptides on glass microchips.Structural and functional analyses of pyroglutamate-amyloid-β-specific antibodies as a basis for Alzheimer immunotherapy.

P2860

Q30316057-D9D88C3A-95FE-4780-8AE4-2D649023DB2D Q36613779-88D3CCEE-A77A-4077-BDC7-420EF101F488 Q36708123-4B5DE538-8C0F-4407-85B2-438D5D254C5A Q38230390-850A5CD8-6C4B-4FAE-B30E-2C2A4FA09764 Q38802991-595F9253-5995-4558-964C-76D946F5A969 Q39106083-5BF94B95-1139-4121-B9BF-13CF294C0AE0 Q46348872-0B19E67D-CD74-4935-A348-556F59E954CE

P2860

Characterization of cerebrospinal fluid aminoterminally truncated and oxidized amyloid-β peptides.

http://www.wikidata.org/entity/Q34244772

description

2012 nî lūn-bûn

@nan

2012 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@ast

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@en

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@nl

type

label

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@ast

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@en

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@nl

prefLabel

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@ast

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@en

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@nl

P1433

Q34244772-E4263330-CCAD-45A6-9D16-7FCF261048D1

P1476

Q34244772-CEB2ED3B-11FB-4810-B339-A8E80CF88633

P2093

Q34244772-207C1505-7708-4E1E-857F-2FF035228505

Q34244772-46609CC1-F281-4216-A750-0F8F0CDA7E12

Q34244772-47448711-3FA4-4B98-94E9-76D1354D76A6

Q34244772-68758C40-874A-4430-8864-1B1823A136A3

Q34244772-7FD65022-6E5C-488A-891F-44961C3A1A10

Q34244772-A9382EA7-39A5-495D-97DE-412C813346B1

Q34244772-B84F2DD7-C66F-421E-8822-3F4547D63A84

P2860

Q34244772-04A6DF6B-DB31-495D-976A-50DED44D7A11

Q34244772-0703FC45-60F0-42A4-9677-3C45DADF4C32

Q34244772-1485FF35-1534-4BB7-A918-64575387B051

Q34244772-1E606F44-E8C0-4DBD-ADB2-91BC1FA1C483

Q34244772-21A410EA-39F1-4BF5-91D7-7CF50E39CF95

Q34244772-3D1351AB-035F-481F-AA6C-69910A97CA69

Q34244772-4290DCDE-FDAC-4781-9FB3-B2CE34F5709D

Q34244772-498C8183-206A-42C9-88B7-DFA56F2E0521

Q34244772-528648B1-D55F-48E6-96A7-66A2F3DE7360

Q34244772-91005B73-9DAD-4C04-B3CB-755166277360

P304

Q34244772-5F2E1188-10AF-466D-BA59-A0F399314849

P31

Q34244772-538A33DE-DBC8-4F55-AF08-8D5E3CC7C171

P356

Q34244772-4B9365B4-3A1F-4E94-824E-74FB5892AF9C

P433

Q34244772-F1B1C9DB-5C33-4AC9-977D-28B914EFE8B6

P478

Q34244772-95730E59-C44F-4112-8F3B-606315A23A34

P577

Q34244772-68A6AF3F-A9DA-4A94-A5FE-BAE7658D8DB7

P698

Q34244772-07E1EB38-2D12-4A5D-8F43-5286323D56AA

P921

Q34244772-0193472F-BFAB-410A-9248-E3F0DFCDB2ED

P356

P1433

Proteomics - Clinical Applications

P1476

Characterization of cerebrospi ...... d oxidized amyloid-β peptides.

@en

P2093

Hermann Esselmann

http://www.w3.org/2001/XMLSchema#string

Jens Wiltfang

http://www.w3.org/2001/XMLSchema#string

Katrin Sparbier

http://www.w3.org/2001/XMLSchema#string

Marion Gallus

http://www.w3.org/2001/XMLSchema#string

Mirko Bibl

http://www.w3.org/2001/XMLSchema#string

Sabine Lehmann

http://www.w3.org/2001/XMLSchema#string

Volker Welge

http://www.w3.org/2001/XMLSchema#string

P2860

A window into the heterogeneity of human cerebrospinal fluid Aβ peptides

Elevation of beta-amyloid peptide 2-42 in sporadic and familial Alzheimer's disease and its generation in PS1 knockout cells.

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

Neurotoxic, redox-competent Alzheimer's beta-amyloid is released from lipid membrane by methionine oxidation.

Amino-truncated beta-amyloid42 peptides in cerebrospinal fluid and prediction of progression of mild cognitive impairment.

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

Determination of beta-amyloid peptide signatures in cerebrospinal fluid using immunoprecipitation-mass spectrometry.

High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.

Characterization of amyloid beta peptides in cerebrospinal fluid by an automated immunoprecipitation procedure followed by mass spectrometry.

Identification of novel APP/Abeta isoforms in human cerebrospinal fluid.

P304

163-169

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PRCA.201100082

http://www.w3.org/2001/XMLSchema#string

P433

3-4

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2012-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22532452

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid